Skip to main content
Premium Trial:

Request an Annual Quote

NIH Awards Johns Hopkins Spinout Circulomics $800K for MicroRNA Tech Development

NEW YORK (GenomeWeb News) – MicroRNA test development firm Circulomics said today it has been awarded two National Institutes of Health grants totaling $800,000 to develop its technology.

The Small Business Innovative Research Phase I awards will go toward the development of Circulomics' Ligo-miR microRNA assay technology and PicoSep single-molecule analysis platform.

The awards were made through NIH's SHIFT initiative to support the commercialization of academic discoveries.

Ligo-miR microRNA profiling technology uses PCR-free, ligation-based multiplexing for the expression profiling of between 10 and 100 microRNA in one streamlined assay, Circulomics said. The technology fits within conventional research workflows, unlike other competing multiplex assay technologies requiring complex assay protocols and expensive detection platforms, the company added.

PicoSep uses micro/nano-microfluidics and single-molecule technology for molecular analysis using as little as five picoliters of sample and less than 100 DNA molecules. The system allows for sensitivity similar to PCR technology but with near-zero sample consumption and less complexity than existing technologies, according to Circulomics.

In addition to the SBIR grants, the Johns Hopkins University spinout received $75,000 from Maryland Technology Development Corporation to develop its first commercial product based on the Ligo-miR technology called Ligo-miR EZ for cancer research. The kit contains all probes, reagents, and buffers for performing 30-plex miRNA profiling on 50 samples. The kit is anticipated to launch in early 2014.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.